DefiniGEN licences lung stem cell technology from Cambridge University – Business Weekly
Business Weekly |
DefiniGEN licences lung stem cell technology from Cambridge University
Business Weekly Cambridge stem cell products pioneer DefiniGEN has strengthened its IP portfolio with a licence for cutting edge lung stem cell technology from the University of Cambridge. The technology will be used by DefiniGEN to develop new, optimised cell … DefiniGEN Licences Lung Stem Cell Technology from University of Cambridge |
